Pharma and biotech stakeholders applauded the vote as Amsterdam achieved the hightest rate of acceptance of the EMA staff for relocatation, according to a survey. Source: BioSpace

Less than one week after the FDA cleared Innovative Health Solutions' NSS-2 Bridge, the company announced it will expand its payroll to include a number of new businesses. Source: BioSpace

Blinded period evaluated the safety of Viaskin Peanut versus placebo in children four to 11 years of age, Including patients with a history of severe anaphylaxis. Source: BioSpace

The company is weeks away from completing its rolling NDA for Patisiran. Source: BioSpace

Kamada now maintains full, worldwide commercial rights to its inhaled AAT. Source: BioSpace

Peptidream has scored another billion dollar-plus agreement to develop peptide-based therapies aimed at the treatment multiple disease targets. Source: BioSpace

Data will be submitted to health authorities globally, including the FDA and EMA. Source: BioSpace

Researchers are making great headway against cancer, even though it's currently still the second-leading cause of death in the U.S. Source: BioSpace

This biotech has had a year where its stock had grown 20 percent and roller-coastered down 20 percent, several times. Source: BioSpace

Genentech announced that its Phase III HAVEN 3 study of Hemlibra in adults and adolescents with hemophilia A without inhibitors to factor VIII had positive results. Source: BioSpace